Terbinafine Hydrochloride
Product Images NDC 31722-209

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 31722-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a183255-figure-01 (3a183255 Figure 01)

This is a report on adverse events for a medication trial involving Lamisit and placebo. The report includes the number and percentages of patients who experienced certain symptoms while taking the medication. The symptoms are categorized as Headache, Gastrointestinal Symptoms (including diarrhea, dyspepsia, abdominal pain, nausea, and flatulence), Dermatological Symptoms (including rash, pruritus, and urticaria), and Abnormal Liver Enzymes. Taste disturbance and Visual Disturbance were also reported. One patient had liver enzyme abnormalities that were 22 times the upper limit of normal range.*

FDA Label Image

3a183255-figure-02 (3a183255 Figure 02)

FDA Label Image

3a183255-figure-03 (3a183255 Figure 03)

This is a list of symptoms that includes nausea, stomach pain, rash, headache, vomiting, dizziness, and frequent urination. It may indicate a medical condition that requires further evaluation and diagnosis by a healthcare professional.*

FDA Label Image

3a183255-figure-04 (3a183255 Figure 04)

This appears to be a list of symptoms related to liver dysfunction such as jaundice, upper right abdominal pain, dark urine, and pale or light colored stools. Other common symptoms include nausea, poor appetite, tiredness, and vomiting. If you are experiencing these symptoms, it is important to seek medical attention as soon as possible.*

FDA Label Image

3a183255-figure-05 (3a183255 Figure 05)

This is the information for the drug Terbinafine Hydrochloride, which is available in the form of tablets of strength 250mg. The drug is used for treating certain types of fungal infections. The prescription label and the package insert should be referred to for details regarding dosage information. The tablets should be stored between 20°C to 25°C with protection from light. The manufacturer of the drug is Camber Pharmaceuticals Inc. located in Piscataway, NJ, and it is manufactured by InvaGen Pharmaceuticals Inc. located in Hauppauge, NY.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.